Biogen (BIIB) Work In Process (2010 - 2018)

Biogen (BIIB) has reported Work In Process for 9 consecutive years, with $606.7 million the latest figure, recorded in Q4 2018.

• In Q4 2018, Work In Process changed 0.17% year-over-year to $606.7 million; the TTM figure through Dec 2018 stood at $606.7 million (changed 0.17% YoY), while the FY2018 annual figure was $606.7 million, changed 0.17% from the prior year.
• Work In Process came in at $606.7 million for Q4 2018 at Biogen, roughly flat from $605.7 million in the prior quarter.
• The five-year high for Work In Process was $698.7 million in Q4 2016, with the low at $511.5 million in Q4 2014.
• Average Work In Process over 5 years is $600.0 million, with a median of $605.7 million recorded in 2017.
• Across the five-year window, Work In Process grew 20.97% in 2016 and decreased 13.31% in 2017, its largest moves.
• Year by year, Work In Process stood at $511.5 million in 2014, then advanced by 12.92% to $577.6 million in 2015, then advanced by 20.97% to $698.7 million in 2016, then fell by 13.31% to $605.7 million in 2017, then gained by 0.17% to $606.7 million in 2018.
• According to Business Quant data, Work In Process over the past three periods registered $606.7 million, $605.7 million, and $698.7 million for Q4 2018, Q4 2017, and Q4 2016 respectively.